Biokine: BioLineRx Completes Recruitment into the Triple Combination Arm of the Motixafortide (BL-8040) COMBAT/KEYNOTE-202 Study in Metastatic Pancreatic Cancer – CBI
Homepage/Press Release/Biokine: BioLineRx Completes Recruitment into the Triple Combination Arm of the Motixafortide (BL-8040) COMBAT/KEYNOTE-202 Study in Metastatic Pancreatic Cancer
Press Release
Biokine: BioLineRx Completes Recruitment into the Triple Combination Arm of the Motixafortide (BL-8040) COMBAT/KEYNOTE-202 Study in Metastatic Pancreatic Cancer